CELZ Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 24, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Creative Medical Technology Holdings Inc (CELZ)

Based on 7 analysts giving stock ratings to Creative Medical Technology Holdings Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
57
Hold
14
Sell
0
Strong Sell
0
Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings Inc. Stock Analysis CELZ

United States Health Care Nano Cap Report:
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Read More

Creative Medical Technology Holdings Inc (CELZ) Chart

Key Statistics of Creative Medical Technology Holdings Inc (CELZ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.20$2.27

Today's Open

$2.20

Volume

11.96K

P/E Ratio (TTM)

-

52 Week Range

$1.50$6.25

Market Cap

8.24M

Avg. Volume

59.10K

Dividend Yield

-

Financial Metrics & Statements of Creative Medical Technology Holdings Inc (CELZ)

FAQ's for Creative Medical Technology Holdings Inc (CELZ)

  • According to Musaffa’s Shariah screening methodology, Creative Medical Technology Holdings Inc (CELZ) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.